sunvozertinib,osimertinib,amivantamab
astrazeneca,dizal pharmaceuticals,janssen
['sunvozertinib', 'tagrisso', 'rybrevant', '$jnj', '$azn', 'dizal']
are these dizal data too good to be true? sunvozertinib seems v active in egfr exon20 ins (60% orr, incl in some $jnj rybrevant progressers), and in egfr sensitizing, incl in t790m (post $azn tagrisso??) #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.